Literature DB >> 17709578

Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography.

Tomohiro Iida.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17709578      PMCID： PMC1954907          DOI： 10.1136/bjo.2007.116160

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  34 in total

1.  Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.

Authors:  Adam H Rogers; Adam Martidis; Paul B Greenberg; Carmen A Puliafito
Journal:  Am J Ophthalmol       Date:  2002-10       Impact factor: 5.258

2.  Pathological features of surgically excised polypoidal choroidal vasculopathy membranes.

Authors:  Sachiko Kuroiwa; Hisashi Tateiwa; Toshio Hisatomi; Tatsuro Ishibashi; Nagahisa Yoshimura
Journal:  Clin Exp Ophthalmol       Date:  2004-06       Impact factor: 4.207

3.  Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy.

Authors:  Masami Nakajima; Mitsuko Yuzawa; Hiroyuki Shimada; Ryusaburo Mori
Journal:  Jpn J Ophthalmol       Date:  2004 May-Jun       Impact factor: 2.447

4.  Polypoidal choroidal vasculopathy: natural history.

Authors:  Masanobu Uyama; Mitsumasa Wada; Yoshimi Nagai; Takashi Matsubara; Hiroshi Matsunaga; Ichiro Fukushima; Kanji Takahashi; Miyo Matsumura
Journal:  Am J Ophthalmol       Date:  2002-05       Impact factor: 5.258

5.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.

Authors:  H Terasaki; Y Miyake; T Suzuki; M Nakamura; T Nagasaka
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

6.  Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.

Authors:  Kenichiro Sho; Kanji Takahashi; Haruhiko Yamada; Mitsumasa Wada; Yoshimi Nagai; Tsuyoshi Otsuji; Maki Nishikawa; Yumiko Mitsuma; Yukari Yamazaki; Miyo Matsumura; Masanobu Uyama
Journal:  Arch Ophthalmol       Date:  2003-10

7.  Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.

Authors:  Sung Chul Lee; Youl Seok Seong; Sung Soo Kim; Hyung Jun Koh; Oh Woong Kwon
Journal:  Ophthalmologica       Date:  2004 May-Jun       Impact factor: 3.250

Review 8.  Polypoidal choroidal vasculopathy in Chinese patients.

Authors:  A K H Kwok; T Y Y Lai; C W N Chan; E-L Neoh; D S C Lam
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

9.  Treatment of polypoidal choroidal vasculopathy with photodynamic therapy.

Authors:  Richard F Spaide; Irene Donsoff; Deborah L Lam; Lawrence A Yannuzzi; Lee M Jampol; Jason Slakter; John Sorenson; K Bailey Freund
Journal:  Retina       Date:  2002-10       Impact factor: 4.256

10.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079
View more
  4 in total

1.  Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.

Authors:  Adrian Koh; Timothy Y Y Lai; Kanji Takahashi; Tien Y Wong; Lee-Jen Chen; Paisan Ruamviboonsuk; Colin S Tan; Chrystel Feller; Philippe Margaron; Tock H Lim; Won Ki Lee
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

2.  Combined therapy and antivascular endothelial growth factor monotherapies for polypoidal choroidal vasculopathy: A protocol for the systematic review and network meta-analysis of efficacy and safety.

Authors:  Yun Zhang; Xun Li; Xiaoye Chen; Zhaolun Cai; Zirong Zhang; You Tang; Tiancong Chang; Misha Chen; Meixia Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

3.  REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS Study.

Authors:  Adrian Koh; Timothy Y Y Lai; Wen Bin Wei; Ryusaburo Mori; Harumi Wakiyama; Kyu Hyung Park; Fariza Ngah; Wayne Macfadden; Cornelia Dunger-Baldauf; Soumil Parikh
Journal:  Retina       Date:  2020-08       Impact factor: 3.975

4.  Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.

Authors:  Tock H Lim; Timothy Y Y Lai; Kanji Takahashi; Tien Y Wong; Lee-Jen Chen; Paisan Ruamviboonsuk; Colin S Tan; Won Ki Lee; Chui Ming Gemmy Cheung; Nor Fariza Ngah; Ramune Patalauskaite; Philippe Margaron; Adrian Koh
Journal:  JAMA Ophthalmol       Date:  2020-09-01       Impact factor: 7.389
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.